Patent: 9,340,538
✉ Email this page to a colleague
Summary for Patent: 9,340,538
| Title: | Dihydropyrimidine compounds and their application in pharmaceuticals |
| Abstract: | Provided herein are dihydropyrimidine compounds and their pharmaceutical applications, especially for use in treating and preventing HBV diseases. Specifically, provided herein are compounds having Formula (I) or (Ia), or an enantiomer, a diastereoisomer, a tautomer, a hydrate, a solvate, or a pharmaceutically acceptable salt thereof, wherein the variables of the formulas are as defined in the specification. Also provided herein is the use of the compounds having Formula (I) or (Ia), or an enantiomer, a diastereoisomer, a tautomer, a hydrate, a solvate, or a pharmaceutically acceptable salt thereof for treating and preventing HBV diseases. ##STR00001## |
| Inventor(s): | Zhang; Yingjun (Dongguan, CN), Ren; Qingyun (Dongguan, CN), Liu; Xinchang (Dongguan, CN), Goldmann; Siegfried (Wuppertal, DE) |
| Assignee: | SUNSHINE LAKE PHARMA CO., LTD. (Dongguan, Guangdong, CN) |
| Application Number: | 14/416,061 |
| Patent Claims: | see list of patent claims |
Details for Patent 9,340,538
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Hoffmann-la Roche Inc. | ROFERON-A | interferon alfa-2a | For Injection | 103145 | 06/04/1986 | ⤷ Try a Trial | 2039-02-26 |
| Biogen Inc. | AVONEX | interferon beta-1a | For Injection | 103628 | 05/17/1996 | ⤷ Try a Trial | 2039-02-26 |
| Biogen Inc. | AVONEX | interferon beta-1a | Injection | 103628 | 05/28/2003 | ⤷ Try a Trial | 2039-02-26 |
| Biogen Inc. | AVONEX | interferon beta-1a | Injection | 103628 | 02/27/2012 | ⤷ Try a Trial | 2039-02-26 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
